GB0224013D0 - A protein involved in therapy - Google Patents

A protein involved in therapy

Info

Publication number
GB0224013D0
GB0224013D0 GBGB0224013.3A GB0224013A GB0224013D0 GB 0224013 D0 GB0224013 D0 GB 0224013D0 GB 0224013 A GB0224013 A GB 0224013A GB 0224013 D0 GB0224013 D0 GB 0224013D0
Authority
GB
United Kingdom
Prior art keywords
therapy
protein involved
protein
involved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0224013.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Oxford Glycosciences UK Ltd
Original Assignee
Bayer AG
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Oxford Glycosciences UK Ltd filed Critical Bayer AG
Priority to GBGB0224013.3A priority Critical patent/GB0224013D0/en
Publication of GB0224013D0 publication Critical patent/GB0224013D0/en
Priority to PCT/GB2003/004477 priority patent/WO2004035139A1/en
Priority to AU2003274328A priority patent/AU2003274328A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0224013.3A 2002-10-15 2002-10-15 A protein involved in therapy Ceased GB0224013D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0224013.3A GB0224013D0 (en) 2002-10-15 2002-10-15 A protein involved in therapy
PCT/GB2003/004477 WO2004035139A1 (en) 2002-10-15 2003-10-15 Regulation of mkk3
AU2003274328A AU2003274328A1 (en) 2002-10-15 2003-10-15 Regulation of mkk3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0224013.3A GB0224013D0 (en) 2002-10-15 2002-10-15 A protein involved in therapy

Publications (1)

Publication Number Publication Date
GB0224013D0 true GB0224013D0 (en) 2002-11-27

Family

ID=9945977

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0224013.3A Ceased GB0224013D0 (en) 2002-10-15 2002-10-15 A protein involved in therapy

Country Status (3)

Country Link
AU (1) AU2003274328A1 (en)
GB (1) GB0224013D0 (en)
WO (1) WO2004035139A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114258317A (en) * 2019-06-18 2022-03-29 斯克里普斯研究学院 Methods and compositions for treating inflammatory disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326469B1 (en) * 1994-04-22 2001-12-04 Sugen, Inc. Megakaryocytic protein tyrosine kinases
US6136596A (en) * 1995-05-19 2000-10-24 University Of Massachusetts Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
US5736381A (en) * 1995-05-19 1998-04-07 Davis; Roger J. Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
EP1174129A1 (en) * 2000-07-17 2002-01-23 Zenner, Hans Peter, Prof. Dr. med. Use of a matrix-metalloprotease inhibitor for the treatment of cancer
EP1201765A3 (en) * 2000-10-16 2003-08-27 Axxima Pharmaceuticals Aktiengesellschaft Cellular kinases involved in cytomegalovirus infection and their inhibition

Also Published As

Publication number Publication date
AU2003274328A1 (en) 2004-05-04
AU2003274328A8 (en) 2004-05-04
WO2004035139A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
GB0206033D0 (en) Compounds useful in therapy
GB0219776D0 (en) A protein involved in carcinoma
AU2003227861A8 (en) Protein involved in cancer
GB0223272D0 (en) A protein involved in therapy
GB0224014D0 (en) A protein involved in therapy
GB0224013D0 (en) A protein involved in therapy
GB0201808D0 (en) Protein
GB0229902D0 (en) A protein involved in therapy
GB0223958D0 (en) A protein involved in therapy
GB0223292D0 (en) A protein involved in therapy
AU2003278718A8 (en) Stars-a muscle-specification-binding protein
GB0204735D0 (en) Protein
GB0202748D0 (en) Protein
GB0221488D0 (en) A protein involved in carcinoma
GB0221538D0 (en) A protein involved in carcinoma
GB0222483D0 (en) A protein involved in carcinoma
GB0308327D0 (en) A protein involved in cancer
GB0221487D0 (en) A protein involved in pancreatic cancer
GB0229875D0 (en) Protein involved in cancer
GB0230023D0 (en) A new protein
GB0228311D0 (en) A new protein
GB0203160D0 (en) Protein
GB0202666D0 (en) Protein
GB0203161D0 (en) Protein
GB0215229D0 (en) Protein

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)